Search

everythinglearnresearchcommunity

for

Search:↓

Chitosan is a sustainable, versatile ingredient in cosmetics, enhancing skin hydration and anti-aging while promoting eco-friendly practices.

Keratin 15 helps maintain tissue integrity and is reduced in activated keratinocytes.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

Humans and pets share similar allergy mechanisms, and studying pet allergies can help treat both human and animal allergies.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

The study was retracted.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Janus kinase inhibitors show promise for treating alopecia areata in children.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Daily use of emollients from birth may reduce atopic dermatitis in infants, but results are mixed.

The study developed a successful mouse model to study skin infections, highlighting the importance of choosing the right fungal strains.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Asthma may increase the risk of alopecia areata.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.